市場調查報告書

心臟麻痺治療的全球市場:2020年-2026年

Global Cardiac Arrest Treatment Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949458
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
心臟麻痺治療的全球市場:2020年-2026年 Global Cardiac Arrest Treatment Market 2020-2026
出版日期: 2020年05月22日內容資訊: 英文
簡介

全球心臟麻痺治療市場,預計到2026年踏實持續成長。市場擴大的原動力,是老年人口的增加和心血管疾病(CVD)的盛行率上升等要素。隨著人口增加,心臟異常的人數增加,各國政府為了對應患者的增加積極提出CVD治療支援的計劃。

本報告提供全球心臟麻痺治療市場調查,市場概要,競爭情形,決定市場方向性決策的要素,各治療法,各地區的分析,企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與考察

  • 調查範圍
  • 分析師的考察與市場的最新趨勢
  • 法律規章

第3章 競爭情形

  • 各公司的佔有率分析
  • 主要策略分析
  • 主要企業分析
    • Koninklijke Philips NV
    • ZOLL Medical Corp.
    • Abbott Laboratories
    • Stryker Corp.
    • Boston Scientific Corp.

第4章 市場決策要素

  • 成長促進因素
  • 成長阻礙因素
  • 市場機會

第5章 市場區隔

  • 各治療法市場
    • 醫藥品
    • 醫療設備

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • AstraZeneca PLC
  • Avive Solutions, Inc.
  • Boston Scientific Corp.
  • Cardiac Science Corp.
  • General Electric Co.
  • HeartSine Technologies, Ltd.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • NeuroproteXeon, Inc.
  • Pfizer Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Stryker Corp.
  • WEINMANN Emergency Medical Technology GmbH + Co. KG
  • ZOLL Medical Corp.
目錄
Product Code: OMR2021777

Global Cardiac Arrest Treatment Market Size, Share & Trends Analysis Report by Treatment (Drugs and Medical Devices) and Forecast 2020-2026

The global cardiac arrest treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population and rising prevalence of cardiovascular diseases (CVDs). With the increasing population, the number of people suffering from cardiac irregularities are increasing. To cater the patient base, the government organizations are actively launching plans in support of CVD. For instance, China PEACE Millions Persons Project was established by the Ministry of Finance in 2014. It is a continuous government-funded initiative with the aim of enrolling 5 million people to improve CVD risk factors in China.

The cardiac arrest treatment market is classified on the basis of treatment, which includes drugs and medical devices. The drugs segment is further classified into vasopressors, corticosteroids, anti-arrhythmic drugs, and others. The medical devices segment in the cardiac arrest market is further sectioned into defibrillators, cardiac resynchronization therapy (CRT), and others. Among these two, the medical devices are majorly used in the treatment of cardiac arrest across the globe. The key players of the cardiac arrest treatment market such as Koninklijke Philips N.V. are offering AED (Automated External Defibrillator).

Geographically, the global cardiac arrest treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and technologically advanced healthcare infrastructure, contributes considerably in the cardiac arrest treatment market. The growth of the market in the US is further supported by the government initiatives and programs for the rising prevalence of CVD. For instance, American Heart Association (AHA) collaborated with Koninklijke Philips N.V. and started a 'Connected Pulse' program, in order to increase the survival rates of sudden cardiac arrest.

The global cardiac arrest treatment market is influenced by product development and advancements conducted by the market players. The key players of the cardiac arrest treatment market include ZOLL Medical Corp., General Electric Co., Abbott Laboratories, Stryker Corp., Boston Scientific Corp., and Koninklijke Philips N.V. These players are playing a significant role in the growth of the cardiac arrest treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global cardiac arrest treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Cardiac Arrest Treatment Market Research and Analysis by Treatment

The Report Covers:

  • Comprehensive research methodology of the global cardiac arrest treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cardiac arrest treatment market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Koninklijke Philips N.V.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. ZOLL Medical Corp.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Abbott Laboratories
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Stryker Corp.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Boston Scientific Corp.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cardiac Arrest Treatment Market by Treatment
    • 5.1.1. Drugs
      • 5.1.1.1. Vasopressors
      • 5.1.1.2. Corticosteroids
      • 5.1.1.3. Anti-arrhythmic Drugs
      • 5.1.1.4. Others (Beta blockers and Fibrinolytic drugs)
    • 5.1.2. Medical Devices
      • 5.1.2.1. Defibrillators
      • 5.1.2.2. Cardiac Resynchronization Therapy (CRT)
      • 5.1.2.3. Others (Ventricular Assist Devices (VADs))

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. AstraZeneca PLC
  • 7.3. Avive Solutions, Inc.
  • 7.4. Boston Scientific Corp.
  • 7.5. Cardiac Science Corp.
  • 7.6. General Electric Co.
  • 7.7. HeartSine Technologies, Ltd.
  • 7.8. Koninklijke Philips N.V.
  • 7.9. Medtronic PLC
  • 7.10. NeuroproteXeon, Inc.
  • 7.11. Pfizer Inc.
  • 7.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 7.13. Stryker Corp.
  • 7.14. WEINMANN Emergency Medical Technology GmbH + Co. KG
  • 7.15. ZOLL Medical Corp.

LIST OF TABLES

  • 1. GLOBAL CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 2. GLOBAL CARDIAC ARREST TREATMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL CARDIAC ARREST TREATMENT MEDICAL DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 5. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 6. NORTH AMERICAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 7. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 8. EUROPEAN CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 9. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 10. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)
  • 11. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY TREATMENT, 2019 VS 2026 (%)
  • 2. GLOBAL CARDIAC ARREST TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 3. US CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 4. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. UK CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ROE CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF THE WORLD CARDIAC ARREST TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)